Alanine aminotransferase (ALT/SGPT); aspartate aminotransferase (AST/SGOT); FIB-4 Index (by calculation); platelet count. If FIB-4 Index is >1.29, testing will reflex to Enhanced Liver Fibrosis (ELF™), performed at an additional charge.
3 - 6 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
For more information, please review the literature below.
NAFLD-NASH Capabilities Brochure
Serum and whole blood
Serum: 2 mL divided into two tubes, 1 mL for initial testing and 1 mL for possible reflex
Whole blood: tube filled to capacity
Serum: 1.5 mL divided into two tubes, 0.75 mL for initial testing and 0.75 mL for possible reflex
Whole blood: tube filled to capacity
Gel-barrier tube or red-top tube and lavender-top (EDTA) tube
Serum: Separate from cells within 45 minutes of collection.
Whole blood: Invert EDTA tube immediately 8 to 10 times once tube is filled at the time of collection.
Serum sample for initial testing and whole blood can be stored at room temperature. Serum sample for possible reflex can be stored refrigerated a 2°C to 8°C for 72 hours.
Serum: 1 day; Whole blood: 1 day
Serum: 3 days; Whole blood: 3 days
Serum: Gross hemolysis; improper labeling
Whole blood: Hemolysis; clotted specimen; tube not filled with minimum volume; improper labeling; transfer tubes with whole blood; specimen diluted or contaminated with IV fluid; specimen received with plasma removed; specimen collected in any anticoagulant other than EDTA
According to the 2022 American Association of Clinical Endocrinology clinical practice guidelines, patients considered at high risk for Nonalcoholic Fatty Liver Disease (NAFLD) should be screened for NAFLD and advanced fibrosis using the following blood-based tests:
• To assess the risk of NAFLD with liver fibrosis, use liver fibrosis prediction calculations. The preferred noninvasive initial test is the FIB-4.
• Consider persons belonging to the “high risk” group who have an indeterminate or high FIB-4 score for further workup with an ELF test.
The FIB-4 index is reported to be a simple, accurate, non-invasive, and readily available laboratory test index that can help in the evaluation of patients with NAFLD for the presence of liver fibrosis, indication for liver biopsy, and other liver-related complications.
The Enhanced Liver Fibrosis (ELF™) blood test is a simple, accurate, non-invasive test that provides a simple, unitless numeric score that is generated via an algorithm for use in advanced liver fibrosis. It is indicated as a prognostic marker in conjunction with other laboratory findings and clinical assessments in patients with advanced fibrosis (F3 or F4) due to non-alcoholic steatohepatitis (NASH) to assess the likelihood of progression to cirrhosis and liver-related clinical events. Because ELF™ uses a blood sample rather than a biopsy, it can be used routinely for the same patient over time.
Clumping may cause false low count. Platelet satellitism around neutrophils will cause a pseudothrombocytopenia. RBC or WBC fragments including fragmented fragile leukemic cells and neutrophil pseudoplatelets may cause falsely elevated counts.
AST and ALT: kinetic
Platelet Count: automated cell counter
ELF Reflex if performed: The ELF™ test consists of three fully automated, two-site sandwich immunoassays using direct chemiluminometric technology. The component assays use two monoclonal mouse antibodies: The first antibody is an acridinium ester-labeled antibody. The second antibody is a biotin-labeled antibody. The solid phase contains streptavidin-coated paramagnetic particles. The ELF™ score is derived from an algorithm that combines PIIINP, TIMP-1, and HA. ELF™ is a trademark of Siemens Healthcare Diagnostics.
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
|402175||FIB-4 w/Reflex to ELF||001123||AST (SGOT)||IU/L||1920-8|
|402175||FIB-4 w/Reflex to ELF||001545||ALT (SGPT)||IU/L||1742-6|
|402175||FIB-4 w/Reflex to ELF||015172||Platelets||x10E3/uL||777-3|
|402175||FIB-4 w/Reflex to ELF||011582||FIB-4 Index||N/A|
|Reflex Table for FIB-4 Index|
|Order Code||Order Name||Result Code||Result Name||UofM||Result LOINC|
|Reflex 1||550659||Enhanced Liver Fibrosis (ELF)||550661||ELF(TM) Score||48795-9|
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
CPT Statement/Profile Statement
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf